261 related articles for article (PubMed ID: 29556917)
1. Long-term outcomes of definitive external-beam radiotherapy for non-metastatic castration-resistant prostate cancer.
Aizawa R; Takayama K; Nakamura K; Inoue T; Kobayashi T; Akamatsu S; Yamasaki T; Ogawa O; Mizowaki T
Int J Clin Oncol; 2018 Aug; 23(4):749-756. PubMed ID: 29556917
[TBL] [Abstract][Full Text] [Related]
2. Long-term clinical outcomes of salvage pelvic radiation therapy for oligo-recurrent pelvic lymph nodes after definitive external-beam radiation therapy for non-metastatic prostate cancer.
Sato GE; Aizawa R; Nakamura K; Takayama K; Inoue T; Yamasaki T; Kobayashi T; Akamatsu S; Ogawa O; Mizowaki T
J Radiat Res; 2020 Jul; 61(4):622-628. PubMed ID: 32583860
[TBL] [Abstract][Full Text] [Related]
3. May non-metastatic clinically localized castration-resistant prostate cancer after primary androgen ablation benefit from salvage prostate radiotherapy?
Botticella A; Guarneri A; Filippi AR; Levra NG; Munoz F; Ragona R; Gontero P; Ricardi U
J Cancer Res Clin Oncol; 2013 Nov; 139(11):1955-60. PubMed ID: 24057645
[TBL] [Abstract][Full Text] [Related]
4. Predictors of castration-resistant prostate cancer after dose-escalated external beam radiotherapy.
Spratt DE; Zumsteg ZS; Pei X; Romesser PB; Yamada J; Kollmeier MA; Woo K; Zhang Z; Zelefsky MJ
Prostate; 2015 Feb; 75(2):175-82. PubMed ID: 25327412
[TBL] [Abstract][Full Text] [Related]
5. Salvage external beam radiotherapy for locally recurrent prostate cancer after definitive brachytherapy.
Rutenberg MS; Meister M; Amin PP; Hussain A; Naslund MJ; Kwok Y
Brachytherapy; 2016; 15(6):722-729. PubMed ID: 27693225
[TBL] [Abstract][Full Text] [Related]
6. Prostate-specific antigen doubling time subsequent to radical prostatectomy is a predictor of outcome following salvage external beam radiation therapy: a single-centre experience.
Servoll E; Sæter T; Vlatkovic L; Nesland JM; Waaler G; Axcrona K
Scand J Urol; 2015 Jun; 49(3):218-23. PubMed ID: 25428750
[TBL] [Abstract][Full Text] [Related]
7. Radical prostatectomy versus external-beam radiotherapy for localized prostate cancer: long-term effect on biochemical control-in search of the optimal treatment.
González-San Segundo C; Herranz-Amo F; Alvarez-González A; Cuesta-Álvaro P; Gómez-Espi M; Paños-Fagundo E; Santos-Miranda JA
Ann Surg Oncol; 2011 Oct; 18(10):2980-7. PubMed ID: 21431406
[TBL] [Abstract][Full Text] [Related]
8. Salvage permanent perineal radioactive-seed implantation for treating recurrence of localized prostate adenocarcinoma after external beam radiotherapy.
Aaronson DS; Yamasaki I; Gottschalk A; Speight J; Hsu IC; Pickett B; Roach M; Shinohara K
BJU Int; 2009 Sep; 104(5):600-4. PubMed ID: 19245439
[TBL] [Abstract][Full Text] [Related]
9. Long-term outcomes of combining prostate brachytherapy and metastasis-directed radiotherapy in newly diagnosed oligometastatic prostate cancer: A retrospective cohort study.
Tsumura H; Ishiyama H; Tabata KI; Sekiguchi A; Kawakami S; Satoh T; Kitano M; Iwamura M
Prostate; 2019 Apr; 79(5):506-514. PubMed ID: 30585345
[TBL] [Abstract][Full Text] [Related]
10. Clinical outcomes of patients with localized and locally advanced prostate cancer undergoing high-dose-rate brachytherapy with external-beam radiotherapy at our institute.
Makino T; Mizokami A; Namiki M
Anticancer Res; 2015 Mar; 35(3):1723-8. PubMed ID: 25750334
[TBL] [Abstract][Full Text] [Related]
11. Radiotherapy for isolated lymph node metastases in patients with locally advanced prostate cancer after primary therapy.
Henkenberens C; Merseburger AS; Bengel F; Derlin T; Hueper K; Grünwald V; Christiansen H
World J Urol; 2016 Sep; 34(9):1239-45. PubMed ID: 26612676
[TBL] [Abstract][Full Text] [Related]
12. Impact of percent positive random biopsies on biochemical outcome in prostate cancer patients treated with external beam radiotherapy with or without androgen deprivation.
Igdem S; Abacioglu U; Cetin I; Alco G; Akgun Z; Sengoz M; Bekiroglu N; Turkan S; Okkan S
J BUON; 2009; 14(4):629-34. PubMed ID: 20148454
[TBL] [Abstract][Full Text] [Related]
13. Salvage external beam radiotherapy for clinical failure after cryosurgery for prostate cancer.
McDonough MJ; Feldmeier JJ; Parsai I; Dobelbower RR; Selman SH
Int J Radiat Oncol Biol Phys; 2001 Nov; 51(3):624-7. PubMed ID: 11597801
[TBL] [Abstract][Full Text] [Related]
14. Clinical results of combined treatment conformal high-dose-rate iridium-192 brachytherapy and external beam radiotherapy using staging lymphadenectomy for localized prostate cancer.
Hiratsuka J; Jo Y; Yoshida K; Nagase N; Fujisawa M; Imajo Y
Int J Radiat Oncol Biol Phys; 2004 Jul; 59(3):684-90. PubMed ID: 15183471
[TBL] [Abstract][Full Text] [Related]
15. Effects of perineural invasion on biochemical recurrence and prostate cancer-specific survival in patients treated with definitive external beam radiotherapy.
Peng LC; Narang AK; Gergis C; Radwan NA; Han P; Marciscano AE; Robertson SP; He P; Trieu J; Ram AN; McNutt TR; Griffith E; DeWeese TA; Honig S; Singh H; Greco SC; Tran PT; Deville C; DeWeese TL; Song DY
Urol Oncol; 2018 Jun; 36(6):309.e7-309.e14. PubMed ID: 29551548
[TBL] [Abstract][Full Text] [Related]
16. External beam radiotherapy for clinically node-negative, localized hormone-refractory prostate cancer: impact of pretreatment PSA value on radiotherapeutic outcomes.
Akimoto T; Kitamoto Y; Saito J; Harashima K; Nakano T; Ito K; Yamamoto T; Kurokawa K; Yamanaka H; Takahashi M; Mitsuhashi N; Niibe H
Int J Radiat Oncol Biol Phys; 2004 Jun; 59(2):372-9. PubMed ID: 15145150
[TBL] [Abstract][Full Text] [Related]
17. The effectiveness and side effects of conformal external beam radiotherapy combined with high-dose-rate brachytherapy boost compared to conformal external beam radiotherapy alone in patients with prostate cancer.
Smolska-Ciszewska B; Miszczyk L; Białas B; Fijałkowski M; Plewicki G; Gawkowska-Suwińska M; Giglok M; Behrendt K; Nowicka E; Zajusz A; Suwiński R
Radiat Oncol; 2015 Mar; 10():60. PubMed ID: 25884489
[TBL] [Abstract][Full Text] [Related]
18. Unification of a common biochemical failure definition for prostate cancer treated with brachytherapy or external beam radiotherapy with or without androgen deprivation.
Fitch DL; McGrath S; Martinez AA; Vicini FA; Kestin LL
Int J Radiat Oncol Biol Phys; 2006 Dec; 66(5):1430-9. PubMed ID: 16765527
[TBL] [Abstract][Full Text] [Related]
19. Reirradiation of Prostate Cancer Local Failures After Previous Curative Radiation Therapy: Long-Term Outcome and Tolerance.
Zilli T; Benz E; Dipasquale G; Rouzaud M; Miralbell R
Int J Radiat Oncol Biol Phys; 2016 Oct; 96(2):318-322. PubMed ID: 27475672
[TBL] [Abstract][Full Text] [Related]
20. Efficacy of high-dose palliative radiotherapy for localised, castration-resistant prostate cancer.
White R; Khor R; Bressel M; Duchesne G; Williams S; Bowden P; Tai K; Foroudi F
Clin Oncol (R Coll Radiol); 2015 Jan; 27(1):16-21. PubMed ID: 25445554
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
